Quantcast
Home > Quotes > RWLK
RWLK

ReWalk Robotics Ltd. Ordinary Shares (RWLK) Quote & Summary Data

$3.24
*  
0.14
4.14%
Get RWLK Alerts
*Delayed - data as of Aug. 16, 2019  -  Find a broker to begin trading RWLK now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
9
Today's High / Low
$ 3.40 / $ 3.10
Share Volume
204,366
50 Day Avg. Daily Volume
592,151
Previous Close
$ 3.38
52 Week High / Low
$ 26.9225 / $ 2.46
Market Cap
23,616,716
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
-0.02

Intraday Chart

Shares Traded

Share Volume:
204,366
50 Day Avg. Daily Volume:
592,151

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -7.88

Trading Range

The current last sale of $3.24 is 31.71% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 3.40 $ 26.9225
 Low: $ 3.10 $ 2.46

Company Description (as filed with the SEC)

We are an innovative medical device company that is designing, developing and commercializing robotic exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. We have developed and are continuing to commercialize ReWalk, an exoskeleton designed for individuals with paraplegia that uses our patented tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement. Additionally, we are developing and intend to commercialize a lightweight soft exo-suit, designed to support mobility and/or therapy for individuals suffering from other lower limb disabilities such as stroke, multiple sclerosis, cerebral palsy, Parkinson's disease and elderly assistance. Development of ReWalk took over a decade and was spurred by the experiences of our founder, Dr. Amit Goffer, who became a quadriplegic due to an accident.  ... More ...  



Risk Grade

Where does RWLK fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 3.40
Open Date:
Aug. 16, 2019
Close Price:
$ 3.24
Close Date:
Aug. 16, 2019


Consensus Recommendation

Analyst Info